Category: Peer-reviewed

Gap junctional coupling in the vertebrate retina: Variations on one theme?

by  •  • 0 Comments

Publication date: May 2013
Source:Progress in Retinal and Eye Research, Volume 34
Author(s): Béla Völgyi , Tamás Kovács-Öller , Tamás Atlasz , Márta Wilhelm , Róbert Gábriel
Gap junctions connect cells in the bodies of all multicellular organisms, forming either homologous or heterologous (i.e. established between identical or different cell types, respectively) cell-to-cell contacts by utilizing identical (homotypic) or different (heterotypic) connexin protein subunits. Gap junctions in the nervous system serve electrical signaling between neurons, thus they are also called electrical synapses. Such electrical synapses are particularly abundant in the vertebrate retina where they are specialized to form links between neurons as well as glial cells. In this article, we summarize recent findings on retinal cell-to-cell coupling in different vertebrates and identify general features in the light of the evergrowing body of data. In particular, we describe and discuss tracer coupling patterns, connexin proteins, junctional conductances and modulatory processes. This multispecies comparison serves to point out that most features are remarkably conserved across the vertebrate classes, including (i) the cell types connected via electrical synapses; (ii) the connexin makeup and the conductance of each cell-to-cell contact; (iii) the probable function of each gap junction in retinal circuitry; (iv) the fact that gap junctions underlie both electrical and/or tracer coupling between glial cells. These pan-vertebrate features thus demonstrate that retinal gap junctions have changed little during the over 500 million years of vertebrate evolution. Therefore, the fundamental architecture of electrically coupled retinal circuits seems as old as the retina itself, indicating that gap junctions deeply incorporated in retinal wiring from the very beginning of the eye formation of vertebrates. In addition to hard wiring provided by fast synaptic transmitter-releasing neurons and soft wiring contributed by peptidergic, aminergic and purinergic systems, electrical coupling may serve as the ‘skeleton’ of lateral processing, enabling important functions such as signal averaging and synchronization.

Read more →

Corneal endothelial regeneration and tissue engineering

by  •  • 0 Comments

Publication date: Available online 23 January 2013
Source:Progress in Retinal and Eye Research
Author(s): Tatsuya Mimura , Satoru Yamagami , Shiro Amano
Human corneal endothelial cells (HCECs) have a limited proliferative capacity. Descemet stripping with automated endothelial keratoplasty (DSAEK) has become the preferred method for the treatment of corneal endothelial deficiency, but it requires a donor cornea. To overcome the shortage of donor corneas, transplantation of cultured HCEC sheets has been attempted in experimental studies. This review summarizes current knowledge about the mechanisms of corneal endothelial wound healing and about tissue engineering for the corneal endothelium. We also discuss recent work on tissue engineering for DSAEK grafts using cultured HCECs and HCEC precursor cell isolation method (the sphere-forming assay). DSAEK grafts (HCEC sheets) were constructed by seeding cultured HCECs on human amniotic membrane, thin human corneal stroma, and collagen sheets. The pump function of the HCEC sheets thus obtained was approximately 75%–95% of that for human donor corneas. HCEC sheets were transplanted onto rabbit corneas after DSAEK. While the untransplanted control group displayed severe stromal edema, the transplanted group had clear corneas throughout the observation period. The sphere-forming assay using donor human corneal endothelium or cultured HCECs can achieved mass production of human corneal endothelial precursors. These findings indicate that cultured HCECs transplanted after DSAEK can perform effective corneal dehydration in vivo and suggest the feasibility of employing the transplantation of cultured HCECs to treat endothelial dysfunction. Additionally, corneal endothelial precursors may be an effective strategy for corneal endothelial regeneration.

Read more →

Macular telangiectasia type 2

by  •  • 0 Comments

Publication date: May 2013
Source:Progress in Retinal and Eye Research, Volume 34
Author(s): Peter Charbel Issa , Mark C. Gillies , Emily Y. Chew , Alan C. Bird , Tjebo F.C. Heeren , Tunde Peto , Frank G. Holz , Hendrik P.N. Scholl
Macular telangiectasia type 2 is a bilateral disease of unknown cause with characteristic alterations of the macular capillary network and neurosensory atrophy. Its prevalence may be underestimated and has recently been shown to be as high as 0.1% in persons 40 years and older. Biomicroscopy may show reduced retinal transparency, crystalline deposits, mildly ectatic capillaries, blunted venules, retinal pigment plaques, foveal atrophy, and neovascular complexes. Fluorescein angiography shows telangiectatic capillaries predominantly temporal to the foveola in the early phase and a diffuse hyperfluorescence in the late phase. High-resolution optical coherence tomography (OCT) may reveal disruption of the photoreceptor inner segment–outer segment border, hyporeflective cavities at the level of the inner or outer retina, and atrophy of the retina in later stages. Macular telangiectasia type 2 shows a unique depletion of the macular pigment in the central retina and recent therapeutic trials showed that such depleted areas cannot re-accumulate lutein and zeaxanthin after oral supplementation. There have been various therapeutic approaches with limited or no efficacy. Recent clinical trials with compounds that block vascular endothelial growth factor (VEGF) have established the role of VEGF in the pathophysiology of the disease, but have not shown significant efficacy, at least for the non-neovascular disease stages. Recent progress in structure–function correlation may help to develop surrogate outcome measures for future clinical trials.In this review article, we summarize the current knowledge on macular telangiectasia type 2, including the epidemiology, the genetics, the clinical findings, the staging and the differential diagnosis of the disease. Findings using retinal imaging are discussed, including fluorescein angiography, OCT, adaptive optics imaging, confocal scanning laser ophthalmoscopy, and fundus autofluorescence, as are the findings using visual function testing including visual acuity and fundus-controlled microperimetry. We provide an overview of the therapeutic approaches for both non-neovascular and neovascular disease stages and provide a perspective of future directions including animal models and potential therapeutic approaches.

Highlights

► Macular telangiectasia (MacTel) type 2 is a neurodegenerative disease affecting the central retina. ► Its prevalence has long been underestimated and may be as high as 0.1%. ► There is central depletion of macular pigment and hyporeflective retinal cavities on OCT imaging. ► Vascular endothelial growth factor (VEGF) appears to play a significant role in the pathophysiology. ► Anti-VEGF therapy may show efficacy in neovascular disease only.

Read more →

Optical plasticity in fish lenses

by  •  • 0 Comments

Publication date: May 2013
Source:Progress in Retinal and Eye Research, Volume 34
Author(s): Ronald H.H. Kröger
In a typical fish eye, the crystalline lens is the only refractive element. It is spherical in shape and has high refractive power. Most fish species have elaborate color vision and spectral sensitivity may range from the near-infrared to the near-ultraviolet. Longitudinal chromatic aberration exceeds depth of focus and chromatic blur is compensated for by species-specific multifocality of the lens. The complex optical properties of fish lenses are subject to accurate regulation, including circadian reversible adjustments and irreversible developmental tuning. The mechanisms optimize the transfer of visual information to the retina in diverse and variable environments, and allow for rapid evolutionary changes in color vision. Active optical tuning of the lens is achieved by changes in the refractive index gradient and involves layers of mature, denucleated lens fiber cells. First steps have been taken toward unraveling the signaling systems controlling lens optical plasticity. Multifocal lenses compensating for chromatic blur are common in all major groups of vertebrates, including birds and mammals. Furthermore, the optical quality of a monofocal lens, such as in the human eye, is equally sensitive to the exact shape of the refractive index profile. Optical plasticity in the crystalline lens may thus be present in vertebrates in general.

Highlights

► Multifocal crystalline lenses compensate for chromatic defocus. ► Different types of optical plasticity optimize information transfer to the retina. ► Denucleated lens fiber cells participate in the regulation. ► Active optical tuning of the lens explains rapid evolution of color vision. ► Similar mechanisms may be present in vertebrates in general.

Read more →

Bone marrow-CNS connections: Implications in the pathogenesis of diabetic retinopathy

by  •  • 0 Comments

Publication date: September 2012
Source:Progress in Retinal and Eye Research, Volume 31, Issue 5
Author(s): Jane Yellowlees Douglas , Ashay D. Bhatwadekar , Sergio Li Calzi , Lynn C. Shaw , Debra Carnegie , Sergio Caballero , Quihong Li , Alan W. Stitt , Mohan K. Raizada , Maria B. Grant
Diabetic retinopathy is the fourth most common cause of blindness in adults. Current therapies, including anti-VEGF therapy, have partial efficacy in arresting the progression of proliferative diabetic retinopathy and diabetic macular edema. This review provides an overview of a novel, innovative approach to viewing diabetic retinopathy as the result of an inflammatory cycle that affects the bone marrow (BM) and the central and sympathetic nervous systems. Diabetes associated inflammation may be the result of BM neuropathy which skews haematopoiesis towards generation of increased inflammatory cells but also reduces production of endothelial progenitor cells responsible for maintaining healthy endothelial function and renewal. The resulting systemic inflammation further impacts the hypothalamus, promoting insulin resistance and diabetes, and initiates an inflammatory cascade that adversely impacts both macrovascular and microvascular complications, including diabetic retinopathy (DR). This review examines the idea of using anti-inflammatory agents that cross not only the blood–retinal barrier to enter the retina but also have the capability to target the central nervous system and cross the blood–brain barrier to reduce neuroinflammation. This neuroinflammation in key sympathetic centers serves to not only perpetuate BM pathology but promote insulin resistance which is characteristic of type 2 diabetic patients (T2D) but is also seen in T1D. A case series of morbidly obese T2D patients with retinopathy and neuropathy treated with minocycline, a well-tolerated antibiotic that crosses both the blood–retina and blood–brain barrier is presented. Our results indicates that minocycine shows promise for improving visual acuity, reducing pain from peripheral neuropathy, promoting weight loss and improving blood pressure control and we postulate that these observed beneficial effects are due to a reduction of chronic inflammation.

Highlights

► Blocking systemic inflammation may prove an effective means of treating DR. ► High-fat diets promote inflammation in the hypothalamus. ► High-fat diets may play a direct role in the development of DR. ► Anti-inflammatory therapies also address other complications of Type 2 diabetes.

Read more →

Glaucomatous damage of the macula

by  •  • 0 Comments

Publication date: January 2013
Source:Progress in Retinal and Eye Research, Volume 32
Author(s): Donald C. Hood , Ali S. Raza , Carlos Gustavo V. de Moraes , Jeffrey M. Liebmann , Robert Ritch
There is a growing body of evidence that early glaucomatous damage involves the macula. The anatomical basis of this damage can be studied using frequency domain optical coherence tomography (fdOCT), by which the local thickness of the retinal nerve fiber layer (RNFL) and local retinal ganglion cell plus inner plexiform (RGC+) layer can be measured. Based upon averaged fdOCT results from healthy controls and patients, we show that: 1. For healthy controls, the average RGC+ layer thickness closely matches human histological data; 2. For glaucoma patients and suspects, the average RGC+ layer shows greater glaucomatous thinning in the inferior retina (superior visual field (VF)); and 3. The central test points of the 6° VF grid (24-2 test pattern) miss the region of greatest RGC+ thinning. Based upon fdOCT results from individual patients, we have learned that: 1. Local RGC+ loss is associated with local VF sensitivity loss as long as the displacement of RGCs from the foveal center is taken into consideration; and 2. Macular damage is typically arcuate in nature and often associated with local RNFL thinning in a narrow region of the disc, which we call the macular vulnerability zone (MVZ). According to our schematic model of macular damage, most of the inferior region of the macula projects to the MVZ, which is located largely in the inferior quadrant of the disc, a region that is particularly susceptible to glaucomatous damage. A small (cecocentral) region of the inferior macula, and all of the superior macula (inferior VF), project to the temporal quadrant, a region that is less susceptible to damage. The overall message is clear; clinicians need to be aware that glaucomatous damage to the macula is common, can occur early in the disease, and can be missed and/or underestimated with standard VF tests that use a 6° grid, such as the 24-2 VF test.

Read more →

Herpes keratitis

by  •  • 0 Comments

Publication date: January 2013Source:Progress in Retinal and Eye Research, Volume 32 Author(s): A.M. Rowe , A.J. St. Leger , S. Jeon , D.K. Dhaliwal , J.E. Knickelbein , R.L. Hendricks Herpes simplex virus-1 (HSV-1) infects the m…

Read more →

Lutein: More than just a filter for blue light

by  •  • 0 Comments

Publication date: July 2012
Source:Progress in Retinal and Eye Research, Volume 31, Issue 4
Author(s): Aize Kijlstra , Yuan Tian , Elton R. Kelly , Tos T.J.M. Berendschot
Lutein is concentrated in the primate retina, where together with zeaxanthin it forms the macular pigment. Traditionally lutein is characterized by its blue light filtering and anti-oxidant properties. Eliminating lutein from the diet of experimental animals results in early degenerative signs in the retina while patients with an acquired condition of macular pigment loss (Macular Telangiectasia) show serious visual handicap indicating the importance of macular pigment. Whether lutein intake reduces the risk of age related macular degeneration (AMD) or cataract formation is currently a strong matter of debate and abundant research is carried out to unravel the biological properties of the lutein molecule. SR-B1 has recently been identified as a lutein binding protein in the retina and this same receptor plays a role in the selective uptake in the gut. In the blood lutein is transported via high-density lipoproteins (HDL). Genes controlling SR-B1 and HDL levels predispose to AMD which supports the involvement of cholesterol/lutein transport pathways. Apart from beneficial effects of lutein intake on various visual function tests, recent findings show that lutein can affect immune responses and inflammation. Lutein diminishes the expression of various ocular inflammation models including endotoxin induced uveitis, laser induced choroidal neovascularization, streptozotocin induced diabetes and experimental retinal ischemia and reperfusion. In vitro studies show that lutein suppresses NF kappa-B activation as well as the expression of iNOS and COX-2. Since AMD has features of a chronic low-grade systemic inflammatory response, attention to the exact role of lutein in this disease has shifted from a local effect in the eye towards a possible systemic anti-inflammatory function.

Read more →

A contemporary concept of the blood–aqueous barrier

by  •  • 0 Comments

Publication date: January 2013
Source:Progress in Retinal and Eye Research, Volume 32
Author(s): Thomas F. Freddo
This review traces the evolution of the concept of the blood–aqueous barrier (BAB) during the past 20 years. The Classical model simply stipulated that the tight junctions of the iris vasculature and ciliary epithelium excluded plasma proteins from the aqueous humor (AH). It failed to reconcile the presence of AH protein levels equal to 1% of that found in plasma. Moreover, models of barrier kinetics assumed that the processes of AH secretion and plasma protein entry were directly linked. Thus, elevations of AH protein levels could only be explained by a pathological breakdown of the BAB. Over the last 20 years it has been shown that the plasma proteins in normal AH by-pass the posterior chamber entirely. Instead, these proteins diffuse from the capillaries of ciliary body stroma, into the iris stroma and then into the anterior chamber. This creates a reservoir of plasma-proteins in the iris stroma that is not derived from the iris vessels. This reservoir is prevented from diffusing posteriorly by tight junctions in the posterior iris epithelium. The one-way valve created by the pupil resting on the anterior lens capsule, combined with the continuous, forward flow of AH through the pupil, prevents protein reflux into the posterior chamber. Importantly, in the new paradigm, secretion of AH and the entry of plasma proteins into AH, are semi-independent events. This opens the possibility that AH protein levels could increase in the absence of breakdown of the BAB. Clinical consequences of this new paradigm of the BAB are discussed.

Graphical abstract

image

Highlights

A: Classical model -the tight junctions of the non-pigmented ciliary epithelium (•••••) and the iris vascular endothelium are the key elements. Plasma proteins are assumed to be part of aqueous as it is secreted. Elevation of protein concentrations can only be explained by an increase in blood-aqueous barrier permeability. B: New Model – Plasma proteins in aqueous humor diffuse from the ciliary body stroma, to the anterior chamber and outflow pathways (arrows). Protein entry is semi-independent of aqueous production and thus concentration can change within limits, without altering barrier permeability. The anterior and posterior chambers are different environments, with unidirectional aqueous flow and tight junctions of the iris epithelium (•••••) separating them.

► The source and route of plasma protein entry into aqueous humor is described. ► The blood–aqueous barrier is not primarily a barrier between blood and aqueous. ► The blood–aqueous barrier separates different environments in front of and behind the iris. ► Not all clinically observable anterior chamber flare is pathological.

Read more →